Research - Jerusalem, Jerusalem District, Israel
ISK was founded in 2005 by two scientists Prof. Uziel Sandler and Dr. Yoram Devary. It is a privately held company, which is engaged in the discovery and development of innovative treatments for malignant and autoimmune diseases with strong unmet needs.ISK assets are based on novel human secreted peptides, which were discovered by the founders using a revolutionary approach that vastly reducing the amount of time and money required to produce such a result.
Outlook
ShareThis
Google Font API
Microsoft Office 365
DigitalOcean
Google Analytics